Mechanisms of epithelial development and neoplasia in the metanephric kidney

International Journal of Developmental Biology

Volumn 43, Issue 5, 1999, Pages 473-478

  Davies, Jamie A ^a,c   Perera, Ayesh D ^b   Walker, Cheryl L ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Carcinoma; Epithelium; Kidney; von Hippel Landau; Wilms'

Indexed keywords

CARCINOGENESIS; CLEAR CELL CARCINOMA; GENE EXPRESSION; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; KIDNEY DEVELOPMENT; KIDNEY EPITHELIUM; KIDNEY TUMOR; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ANIMALS; CARCINOMA, RENAL CELL; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; NEPHRONS; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PAX2 TRANSCRIPTION FACTOR; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEINS; UROTHELIUM; WILMS TUMOR;

EID: 0032834658     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. CHO, E.A., PATTERSON, L.T., BROOKHISER, W.T., MAH, S., KINTNER, C. and DRESSLER, G.R. (1998). Differential expression and function of cadherin-6 during renal epithelium development. Development 125: 803-812.
2. COLES., H.S.R., BURNE, J.F. and RAFF, M.C. (1993). Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784.
3. COOK, D.M., HINKES, M.T., BERNFIELD, M. and RAUSCHER, F.J. (1996). Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 13: 1789-990.
4. DAVIES, J.A. (1996). Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat. 156: 187-201.
5. DAVIES, J.A. and BARD, J.B.L. (1998). The development of the kidney. Curr. Top. Dev. Biol. 39: 245-301.
6. DAVIES, J.A. and BRÄNDLI, A.W. (1995). The kidney development database, http://www.ana.ed.ac.uk/anatomy/database/kidbase/kidhome.html
7. DAVIES, J.A. and GARROD, D.R. (1995). Induction of early stages of kidney tubule differentiation by lithium ions. Dev. Biol. 167: 50-60.
8. DAVIES, J.A., LYON, M., GALLAGHER, J. and GARROD, D.R. (1995). Sulphated proteoglycan is required for collecting duct growth and branching out not nephron formation during kidney development. Development 121: 1507-1517.
9. DAVIES, J.A., MILLAR, C.B., JOHNSON. E. and MILBRANDT, J. (1999). Regulation of renal collecting duct development by neurturin. Dev. Genet. 24: 284-292.
10. DRESSLER, G.R. and DOUGLASS, E.C. (1992). Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl. Acad. Sci. USA. 89: 1179-1183.
11. DRESSLER, G.R., ROTHENPIELER, D.W., PATTERSON, L.T., WILLIAMS-SIMONS, L. and WESTPHAL, H. (1992). Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362: 65-67.
12. DUDLEY, A.T., LYONS, K.M. and ROBERTSON. E.J. (1995). A requ rement for bone morphogenetic protein 7 during development of the mammalian kidney and eye. Genes Dev. 9: 2795-2807.
13. EKBLOM, P., EKBLOM, M., FECKER. L., KLEIN, G., ZHANG. H-Y., KADOYA, Y., CHU, M-L., MAYER, U. and TIMPL, R. (1994). Role of mesenchymal nidogen for epithelial morphogenesis in vitro. Development 120: 2003-2014.
14. GEIST, R.T. and GUTMANN, D.H. (1995). The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal chord. Cell Growth Differ. 6: 1477-1483.
15. GNARRA, J.R. and DRESSLER, G.R. (1995). Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 55: 4092-4098.
16. GROBSTEIN, C. (1955). Inductive interactions in the development of the mouse metanephros. J. Exp. Zool. 130: 319-340.
17. HENRY, K., YUAN, X., KOSZEWSKI, N.J., ONDA, H., KWIATKOWSKI, D.J. and NOONAN, D.J. (1998). Tuberous sclerosis gene product modulated transcription meidated by steroid hormone receptor family members. J. Biol. Chem. 273: 20535-20539.
18. KLEIN, P.S. and MELTON, D.A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93: 8455-8459.
19. KOSEKI, C., HERZLINGER, D. and AL-AWQATI, Q. (1992). Apoptosis in metanephric development. J. Cell Biol. 119: 1327-1333.
20. KOVACS, G. (1993). Molecular cytogenetics of renal cell tumors. Adv. Cancer Res. 62: 89-124.
21. KREIDBERG, J.A., DONOVAN, M.J., GOLDSTEIN, S.L., RENNKE, H., SHEPHERD, K., JONES, R.C. and JAENISCH, R. (1996). Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122: 3537-3547.
22. KREIDBERG, J.A., SARIOLA, H., LORING, J.M., MAEDA, M., PELLETIER, J., HOUSMAN, D. and JAENISCH, R. (1993). WT-1 is requirec for early kidney development. Cell 74: 679-691.
23. LARSSON, S.H., CHARLIEU, J.P., MIYAGAWA, K., ENGELKAMP, D., RASSOULZADEGAN, M., ROSS, A., CUZIN, F., VAN HEYNINGEN, V. and HASTIE, N.D. (1995). Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401.
24. LELONGT, B., TRUGNAN, G., MURPHY, G. and RONCO, P.M. (1997). Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J. Cell. Biol. 136: 1363-1373.
25. LUO, G., HOFMANN, C., BRUNCKENS, A.L.J.J., SOHOCHI, M., BRADLEY, A. and KARSENTY, G. (1995). BMP7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev. 9: 2308-2820.
26. MELMON, K.L. and ROSEN, S.W. (1964). Lindau's disease: review of the literature and study of a large kindred. Am. J. Med. 36: 595-617.
27. MILBRANDT, J., DE SAUVAGE, F., FAHRNER, T.L., BALOH, R.H., LEITNER, M.L., TANSEY, M.L., LAMPE, P.A., HEUCKEROTH, R.O., KOTZBAUER, P.T., SIMBURGER, K.S., GOLDEN, J.P., DAVIES, J.A., VEJSADE, R., KATO, A.C., HYNES, M., SHERMAN, D., NISHIMURA, M., WANG, L-C., VANDLEN, R., MOFFAT, B., KLEIN, R.D., POULSEN, K., GRAY, C., GARCES, A., HENDERSON, C. E. ,PHILLIPS, H. S. and JOHNSON, E. (1998). Persephin, a neurotrophic factor related to GDNF and Neurturin. Neuron 20: 1-20.
28. MUKHOPADHYAY, D., KNEBELMANNM, B., COHENM, H.T., ANANTHM, S. and SUKHATMEM, V.P. (1997). The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promotor activity. Mol. Cell. Biol. 17: 5629-5639.
29. MÜLLER, U., WANG, D., DENDA, S., MENESES, J., PEDERSEN, R.A. and REICHARDT, L.F. (1997). Integrin alpha8beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88: 603-613.
30. NAGASHIMA, Y., MIYAGI, Y., UDAGAWA, K., TAKI, A., MISUGI, K., SAKAI, N., KONDO, K., KANEKO, S., YAO, M. and SHUIN, T. (1996). Von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization. J. Pathol. 180: 271-274.
31. PAUSE, A., LEE, S., LONERGAN, K.M. and KLAUSNER, R. (1998). The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. Natl. Acad. Sci. USA 95: 993-998.
32. PICHEL, J.G., SHEN, L., SHENG, H.Z., GRANHOLM, A-C., DRAGO, J., GRINBERG, A., LEE, E.J., HUANG, S.P., SAARMA, M., HOFFER, B.J., SARIOLA, H. and WESTPHAL, H. (1996). Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73-76.
33. SAINIO, K., SUVANTO, P., DAVIES, J.A., WARTIOVAARA, J., WARTIOVAARA, K., SAARMA, M., ARUMÄE, U., MENG, X., LINDAHL, M., PACHNIS, V. and SARIOLA, H. (1997). Glial cell-line derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124: 4077-4087.
34. SCHMIDT, C., BLADT, F., GOEDECKE, S., BRINKMANN, V., ZSCHIECHE, W., SHARPE, M., GHERARDI, E. and BIRCHMEIER, C. (1995). Scatter factor/Hepatocyte growth factor is essential for liver development. Nature 373: 699-702.
35. SCHMIDT, L., DUH, F-M., CHEN, F., KISHIDA, T., GLENN, G., CHOYKE, P., SCHERER, S.W., ZHUANG, Z., LUBENSKY, I., DEAN, M., ALLIKMETS, R., CHIDAMBARAM, A., BERGERHEIM, U.R., FELTIS, J.T., CASADEVALL, C., ZAMARRON, A., BERNUES, M., RICHARD, S., LIPS, C.J.M., WALTHER, M.M., TSUI, L-C., GEIL, L., ORCUTT, M.L., STACKHOUSE, T., LIPAN, J., SLIFE, L., BRAUCH, H., DECKER, J., NIEHANS, G., HUGHSON, M.D., MOCH, H., STORKEL, S., LERMAN, M.I., LINEHAN, W.M. and ZBAR, B. (1997). Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet. 16: 68-73.
36. SOUCEK, T., PUSCH, O., WIENECKE, R., DECLUE, J.E. and HENGSTSCHLAGER, M. (1997). Role of tuberous sclerosis gene-2 product in cell cycle control. J. Biol. Chem. 272: 29301-29308.
37. STARK, K., VAINO, S., VASSILEVA, G. and MCMAHON, A.P. (1994). Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372: 679-683.
38. WOOLF, A.S., KOTALSI-JOANNOU, M., HARDMAN, P., ANDERMACHER, E., MOORBY, C., FINE, L.G., JAT, P.S., NOBLE, M.D. and GHERARDI, E. (1995). "Roles of hepatocyte growth factor/scatter factor and the Met receptor in the early development of the metanephros". J. Cell. Biol. 128: 171-184.